Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion type Assertion NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_head.
- NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion description "[ These data provide the first evidence suggesting that polymorphism of the GSTM3 gene contributes to clinical severity in CF, which may have prognostic significance and could prompt to start a more targeted therapy in young patients with CF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_provenance.
- NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion evidence source_evidence_literature NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_provenance.
- NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion SIO_000772 15115915 NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_provenance.
- NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion wasDerivedFrom gad-20150221 NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_provenance.
- NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_assertion wasGeneratedBy ECO_0000203 NP50502.RAIStRlX5m-ib5DXYk-4TsnqCNKLwqcTcKI6I8WPBRbRo130_provenance.